Colleen
Colleen Ankeny, Pine City, MN US
Patent application number | Description | Published |
---|---|---|
20140135672 | ORTHOPEDIC BACK BRACE - Orthopedic braces and associated methods are described for treatment of lower back injuries and chronic back pain. An orthopedic brace may include a pair of back panels, a pair of front panels, and a closure system. A lateral end of each front panel is releasably coupleable to a lateral end of each back panel at a desired angle. A ventral end of each front panel includes an attachment provision configured to allow one of the front panels to releasably attach to the other of the front panels generally over an abdomen of a wearer. The brace also includes a pocket on the ventral end of at least one of the front panels, the pocket configured to temporarily receive a hand of the wearer to aid in donning the orthopedic brace. | 05-15-2014 |
Colleen Caleshu, San Mateo, CA US
Patent application number | Description | Published |
---|---|---|
20130080365 | Phased Whole Genome Genetic Risk In A Family Quartet - An embodiment of the present invention is a method for resolving long-range haplotype phase based on family pedigree data, inheritance state determination, and population linkage disequilibrium data. A method according to an embodiment of the present invention provides for the evaluation of genome wide risk using phased haplotype data. | 03-28-2013 |
Colleen Caporal, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20160070431 | SYNC BASED ON NAVIGATION HISTORY - Disclosed are various examples for syncing files based on a navigation history. A client application maintains a navigation history for a file management system. The client application identifies files and directories accessed according to the navigation history. The identified files or associated metadata are downloaded from the file management system during a sync operation. | 03-10-2016 |
20160070432 | Manipulating Documents in Touch Screen File Management Applications - Disclosed are examples of manipulating documents in file management applications. In one example, a listing of at least one file can be encoded in a user interface of a client application for rendering in a touch screen display. A touch input can be received that designates a selected one of the files, where the touch input can be a gesture performed on the touch screen display. In response to a type of the gesture matching a predefined gesture type, a determination can be made whether at least one of the files is active in the client application and the user interface can be modified to include the at least one of the files and the selected one of the files in response to the at least one of the files. | 03-10-2016 |
20160072841 | COLLABORATION FOR NETWORK-SHARED DOCUMENTS - Disclosed are various embodiments for facilitating collaboration among users for network-shared documents. A computing environment can identify that a particular identifier was used in a communication regarding a file being accessible on various client devices. A suitable task to perform in association with at least one of the plurality of client devices can be identified based on the identifier and a determination can be made whether performance of the task would comply with at least one compliance rule. In response to the performance of the task complying with the at least one compliance rule, the task can be performed. | 03-10-2016 |
Colleen Carkeet, Silver Spring, MD US
Patent application number | Description | Published |
---|---|---|
20120264174 | ASSAY FOR VITAMIN B12 ABSORPTION AND METHOD OF MAKING LABELED VITAMIN B12 - The invention provides methods for labeling vitamin B12 with | 10-18-2012 |
Colleen Csavas, Burgdorf CH
Patent application number | Description | Published |
---|---|---|
20120122227 | GUIDED STRUCTURED TESTING KIT - A guided structured testing kit comprising a test strip container, a test strip meter, a testing protocol advisor, and at least one of diagnostic test strip is presented. The diagnostic test strip comprising a support element, a glucose reagent provided on the support element, and a glycemic context code provided on the support element. The glycemic context code can be machine-readable. The glycemic context code signals a glycemic context to a test strip meter, either upon insertion of the diagnostic test strip or by a user manually inputting the glycemic context into the test strip meter. A method for performing a guided structured test is also provided. | 05-17-2012 |
Colleen Davis, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20130344491 | Random-Primed Transcriptase In-Vitro Transcription Method for RNA Amplification - A random-primed reverse transcriptase-in vitro transcription method of linearly amplifying RNA is provided. According to the methods of the invention, source RNA (or other single-stranded nucleic acid), preferably, mRNA, is converted to double-stranded cDNA using two random primers, one of which comprises a RNA polymerase promoter sequence (“promoter-primer”), to yield a double-stranded cDNA that comprises a RNA polymerase promoter that is recognized by a RNA polymerase. Preferably, the primer for first-strand cDNA synthesis is a promoter-primer and the primer for second-strand cDNA synthesis is not a promoter-primer. The double-stranded cDNA is then transcribed into RNA by the RNA polymerase, optimally in the presence of a reverse transcriptase that is rendered incapable of RNA-dependent DNA polymerase activity during this transcription step. The subject methods produce linearly amplified RNA with little or no 3′ bias in the sequences of the nucleic acid population amplified. | 12-26-2013 |
Colleen Davis, Carlsbad, CA US
Patent application number | Description | Published |
---|---|---|
20150191781 | RANDOM-PRIMED TRANSCRIPTASE IN-VITRO TRANSCRIPTION METHOD FOR RNA AMPLIFICATION - A random-primed reverse transcriptase-in vitro transcription method of linearly amplifying RNA is provided. According to the methods of the invention, source RNA (or other single-stranded nucleic acid), preferably, mRNA, is converted to double-stranded cDNA using two random primers, one of which comprises a RNA polymerase promoter sequence (“promoter-primer”), to yield a double-stranded cDNA that comprises a RNA polymerase promoter that is recognized by a RNA polymerase. Preferably, the primer for first-strand cDNA synthesis is a promoter-primer and the primer for second-strand cDNA synthesis is not a promoter-primer. The double-stranded cDNA is then transcribed into RNA by the RNA polymerase, optimally in the presence of a reverse transcriptase that is rendered incapable of RNA-dependent DNA polymerase activity during this transcription step. The subject methods produce linearly amplified RNA with little or no 3′ bias in the sequences of the nucleic acid population amplified. | 07-09-2015 |
Colleen Dechon, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20150149271 | SYSTEM AND METHOD OF REDEEMING LOYALTY POINTS AT A POINT OF SALE - The systems and methods for redemption of loyalty points to satisfy a transaction are provided. The systems and methods may include APIs that are capable of determining a balance of loyalty points in response to initiation of a payment transaction at the POS. The system may also include APIs that are configured to authorize the transaction. In this regard, the APIs may initiate their requests such that, the results of the requests (e.g., the loyalty point balance and the authorization) are received at substantially the same time. | 05-28-2015 |
Colleen Ennett, White Plains, NY US
Patent application number | Description | Published |
---|---|---|
20100324938 | METHOD AND APPARATUS FOR IDENTIFYING RELATIONSHIPS IN DATA BASED ON TIME-DEPENDENT RELATIONSHIPS - A decision support apparatus ( | 12-23-2010 |
20150208968 | SYSTEM AND METHOD FOR ASSESSMENT OF PATIENT HEALTH BASED ON RECOVERY RESPONSES FROM OXYGEN DESATURATION | 07-30-2015 |
20150254408 | PERSONALIZING PATIENT PATHWAYS BASED ON INDIVIDUAL PREFERENCES, LIFESTYLE REGIME, AND PREFERENCES ON OUTCOME PARAMETERS TO ASSIST DECISION MAKING | 09-10-2015 |
Colleen Garbe-Leprell, Ypsilanti, MI US
Patent application number | Description | Published |
---|---|---|
20100305075 | COMPOSITION AND METHOD OF TREATING HEARING LOSS - A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual components alone. The composition includes a biologically effective amount of vitamin E for inhibiting propagation of lipid peroxidation that contributes to hearing loss. The composition also includes a biologically effective amount of a salicylate for reducing hydroxyl radicals that contribute to hearing loss. A method of treating hearing loss includes the step of internally administering the composition, as described above, to a mammal within three days of trauma to a middle or inner ear of the mammal. In other words, the composition is effective even when administered as late as three days after trauma to a middle or inner ear of a mammal. | 12-02-2010 |
Colleen Gemborys, Bloomington, IN US
Patent application number | Description | Published |
---|---|---|
20140348860 | MEDICAL DEVICES FOR COLLECTING PATHOGENIC CELLS - Disclosed is a medical device constructed and arranged for contact with a flow of blood or other bodily fluid of a patient and including an attached binding agent or a roughened surface that binds to pathogenic cells targeted for elimination from the blood or other bodily fluid. Also disclosed are methods for making and using the device. | 11-27-2014 |
20150080940 | ANTI-TUMOR MACROPHAGE M1 MORPHOLOGY INDUCER - Described are embolization devices which carry M1 macrophage promoting agents and/or M2 macrophage inhibiting agents, as well as methods for their manufacture and use. An illustrative embolization device of the disclosure comprises an embolic body and one or more M1 macrophage promoting agents and/or M2 macrophage inhibiting agents carried by a surface of the embolic body. In certain embodiments the embolic body of the present disclosure comprises an embolic coil or an embolic bead. | 03-19-2015 |
20160038648 | Encapsulated Drug Compositions and Methods of Use Thereof - Various aspects of the present disclosure provide compositions, coatings and implantable devices including a drug and an excipient. In certain embodiments the excipient and the drug are present at a weight ratio of between 10 to 1 and 1 to 10 drug to excipient. In certain other embodiments, the excipient and the drug form particles in which the drug is encapsulated by the excipient. Other aspects of the disclosure provide methods of manufacturing and using such compositions, coatings and implantable devices. | 02-11-2016 |
Colleen Gritzen, Vista, CA US
Patent application number | Description | Published |
---|---|---|
20090275569 | Benzotriazine Inhibitors of Kinases - The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases. | 11-05-2009 |
20110294796 | BENZOTRIAZINE INHIBITORS OF KINASES - The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases. | 12-01-2011 |
Colleen Kalczynski, Shelby Twp., MI US
Patent application number | Description | Published |
---|---|---|
20140260727 | Electric Power Steering Assembly - A rack drive assembly adapted for use in a vehicle electric power steering assembly includes a bearing assembly disposed in a rack housing and carried by a ball nut assembly for rotatably supporting the ball nut assembly relative to a steering member; and a spanner nut carried by the rack housing for securing the bearing assembly in the rack housing. A first isolator, a second isolator and a first shim are provided wherein the first isolator is disposed between an inner surface of the housing and a first surface of an outer race of the bearing, the second isolator is disposed between an opposite second surface of the outer race of said bearing and the first shim, the first shim is disposed between the second isolator and the spanner nut. The first shim is provided with a member configured to be coupled to the housing to allow for axial movement but prevent rotational motion of the shim during installation of the spanner nut. | 09-18-2014 |
Colleen Kelly, Carlsbad, CA US
Patent application number | Description | Published |
---|---|---|
20160025733 | METHODS OF DETECTING PROSTATE CANCER - The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer. | 01-28-2016 |
Colleen Legzdins, West Vancouver CA
Patent application number | Description | Published |
---|---|---|
20140183054 | EFFICIENT TREATMENT OF WASTEWATER USING ELECTROCHEMICAL CELL - An efficient method and system for the electrochemical treatment of waste water comprising organic and/or inorganic pollutants is disclosed. The system comprises an electrolytic cell comprising a solid polymer, proton exchange membrane electrolyte operating without catholyte or other supporting electrolyte. The cell design and operating conditions chosen provide for significantly greater operating efficiency. | 07-03-2014 |
20150298998 | EFFICIENT TREATMENT OF WASTEWATER USING ELECTROCHEMICAL CELL - An efficient method and system for the electrochemical treatment of waste water comprising organic and/or inorganic pollutants is disclosed. The system comprises at least first and second solid polymer electrolyte electrolytic cell stacks in which each cell comprises a solid polymer, proton exchange membrane electrolyte operating without catholyte or other supporting electrolyte. The first and second stacks differ either in construction or operating condition. The cell stack design and operating conditions chosen provide for significantly greater operating efficiency. | 10-22-2015 |
20150321929 | METHOD FOR IMPARTING FILTERING CAPABILITY IN ELECTROLYTIC CELL FOR WASTEWATER TREATMENT - An electrolytic cell, system, and method for the energy efficient electrochemical treatment of wastewater comprising organic and/or inorganic pollutants are disclosed. The system comprises an electrolytic cell comprising a solid polymer, proton exchange membrane electrolyte operating without catholyte or other supporting electrolyte. The electrolytic cell also comprises a filter layer incorporated between the anode fluid delivery layer and the anode flow field plate for removing various contaminants including particulates and/or suspended solids from the wastewater stream. The cell design and operating conditions chosen provide for significantly greater operating efficiency. | 11-12-2015 |
Colleen Leprell, Gainesville, FL US
Patent application number | Description | Published |
---|---|---|
20130078320 | COMPOSITION FOR TREATING HEARING LOSS - A composition to be administered to a mammal for treating hearing loss is disclosed herein. The composition consists essentially of a biologically effective amount of vitamin A, vitamin C, vitamin E, and a vasodilator comprising magnesium. The composition optionally includes a withanolide and/or resveratrol. The vitamin A, vitamin C, vitamin E, and the vasodilator comprising magnesium provides an additive effect that is equal to or greater than a sum of the effects of the individual components. | 03-28-2013 |
Colleen Leprell, Ypsilanti, MI US
Patent application number | Description | Published |
---|---|---|
20110280964 | Composition And Method of Treating Hearing Loss - A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is equal to or greater than a sum of the effect of the individual components. The composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. A method of treating hearing loss includes the step of internally administering the composition including a biologically effective amount of the at least one scavenger of singlet oxygen, the donor antioxidant, the third antioxidant, and the vasodilator to a mammal within three days of trauma to a middle or inner ear of the mammal. | 11-17-2011 |
Colleen Maraffino, Northville, MI US
Patent application number | Description | Published |
---|---|---|
20130175821 | DEPLOYABLE LOAD FLOOR - A vehicle load floor assembly having a load floor coupled with a handle. The handle is operable between first and second positions. At least one support leg is coupled to the load floor. The at least one support leg is retracted when the handle is in the first position and deployed when the handle is in the second position. A base wall supports the at least one support leg, when deployed, to maintain the load floor in a substantially lateral position. The base wall supports an underside of the load floor when the at least one support leg is retracted. | 07-11-2013 |
Colleen Mckirryher, Thomaston, CT US
Patent application number | Description | Published |
---|---|---|
20090294294 | Acid-resistance promoting composition - A composition for providing acid resistance to copper surfaces in the production of multilayered printed circuit boards. The composition comprises an acid, an oxidizer, a five-membered heterocyclic compound and a thiophosphate or a phosphorous sulfide compound. In a preferred embodiment, the phosphorous compound is phosphorus pentasulfide. The composition is applied to a copper or copper alloy substrate and the copper substrate is thereafter bonded to a polymeric material. | 12-03-2009 |
20100170638 | Process for Improving the Adhesion of Polymeric Materials to Metal Surfaces - An adhesion promoting composition and a process for treating metal surfaces with the adhesion promoting composition is described. The adhesion promoting composition comprises an oxidizer, an acid, a corrosion inhibitor, a source of halide ions and a material selected from a mercapto propane sulfonate, mercapto propane sulfonic acid, and bis-sodium sulfopropyl disulfide. The adhesion promoting composition increases the adhesion of polymeric materials to the metal surfaces and also provides increased acid resistance. | 07-08-2010 |
Colleen Mcmaham, Sausalito, CA US
Patent application number | Description | Published |
---|---|---|
20110201771 | BIOSYNTHESIS OF POLYISOPRENOIDS - The synthetic production of cis-1,4-polyisoprene and other cis-1,4-polydienes is achieved by adding isoprene or other diene monomers to a natural rubber latex or washed rubber particles and utilizing various allylic pyrophosphate compounds. The natural rubber latex or washed rubber particles inherently contain an enzyme catalyst and desirably divalent metal cofactors therein and the polymerization can occur over a relatively wide temperature range. The process is believed to be a living carbocationic polymerization. The in vitro produced natural rubber polymers can contain from about 5 to about 30,000 repeat units and are essentially free of non-enzyme catalysts. The invention can be utilized to synthesize polyisoprenoids and precursors to form terpenes, vitamins, steroids, alkaloids, and the like. | 08-18-2011 |
Colleen Mdingi, Germantown, MD US
Patent application number | Description | Published |
---|---|---|
20130331667 | PURIFICATION OF GLUCOSE CONCENTRATION SIGNAL IN AN IMPLANTABLE FLUORESCENCE BASED GLUCOSE SENSOR - Methods, sensors, and systems for determining a concentration of glucose in a medium of a living animal are disclosed. Determining the glucose concentration may involve emitting excitation light from a light source to indicator molecules, generating a raw signal indicative of the amount of light received by a photodetector, purifying and normalizing the raw signal, and converting the normalized signal to a glucose concentration. The purification may involve removing noise (e.g., offset and/or distortion) from the raw signal. The purification and normalization may involve tracking the cumulative emission time that the light source has emitted the excitation light and tracking the implant time that has elapsed since the optical sensor was implanted. The purification and normalization may involve measuring the temperature of the sensor. The purification, normalization, and conversion may involve using parameters determined during manufacturing, in vitro testing, and/or in vivo testing. | 12-12-2013 |
20140018644 | PURIFICATION OF GLUCOSE CONCENTRATION SIGNAL IN AN IMPLANTABLE FLUORESCENCE BASED GLUCOSE SENSOR - Methods, sensors, and systems for determining a concentration of glucose in a medium of a living animal are disclosed. Determining the glucose concentration may involve emitting excitation light from a light source to indicator molecules, generating a raw signal indicative of the amount of light received by a photodetector, purifying and normalizing the raw signal, and converting the normalized signal to a glucose concentration. The purification may involve removing noise (e.g., offset and/or distortion) from the raw signal. The purification and normalization may involve tracking the cumulative emission time that the light source has emitted the excitation light and tracking the implant time that has elapsed since the optical sensor was implanted. The purification and normalization may involve measuring the temperature of the sensor. The purification, normalization, and conversion may involve using parameters determined during manufacturing, in vitro testing, and/or in vivo testing. | 01-16-2014 |
Colleen Meloff, Tampa, FL US
Patent application number | Description | Published |
---|---|---|
20150297194 | LIQUID SAMPLE COLLECTING SYSTEM - In accordance with the present invention, there is provided a liquid sample collection system, which generally comprises a means for grasping or a handle | 10-22-2015 |
Colleen Moraghan, Cold Spring Harbor, NY US
Patent application number | Description | Published |
---|---|---|
20110289524 | System and Method for Set Top Viewing Data - In a video delivery context, collection and analysis of viewing data can provide insight into viewer interaction with video and the Internet. The viewing data can be transmitted in a controlled manner to a data repository. The system can selectively target specific viewers/households to obtain viewing data, which can be combined with demographics, anonymized, and encrypted. Embodiments enable precision selection of media opportunities, by determining detailed characteristics associated with broadcasts including movement of audiences and specific viewer behavior, such as visits to websites on the Internet. The effective yield of broadcasts, including promotional spots and advertisements, can be determined and predicted based on concrete data at a level of detail down to individual viewers. Accordingly, embodiments enable improvement of the effectiveness and return on investment for programming, promotional spots, and advertisements. | 11-24-2011 |
Colleen Novelo, Shingle Springs, CA US
Patent application number | Description | Published |
---|---|---|
20150118332 | NON-TOXIC ECTOPARASITE TREATMENT COMPOSITION AND METHOD OF USE - A non-toxic composition for the treatment and prevention of ectoparasite infestations is provided. In its most basic form, the composition comprises a combination of effective amounts of cinnamon oil, oregano oil and either citronella oil or lavender oil. Additional oils, including both citronella oil and lavender oil, in addition to peppermint oil, orange oil, tea tree oil and rosemary oil may be added to the composition while still maintaining the efficacy of the composition. The composition may be combined with a carrier agent and the combination may be applied to a subject to effect the elimination of ectoparasites and the prevention of new infestations. Preferably, the carrier agent is a shampoo, a conditioner, a non-aqueous spray, a body wash or a lotion. | 04-30-2015 |
Colleen Novielli, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20150154625 | Reward Program for Financial Accounts - A computer system enables a financial institution to award a fixed reward that may include one or more fixed components based on at least one payment criterion when a customer remits a payment in a timely basis. The payment criteria, for example, may include paying a minimum amount for each consecutive billing period in a timely manner over a predetermined calendar interval. When the customer is awarded the fixed reward, the reward may be directed to an account that is designated by the customer. The fixed reward may also include a basic fixed amount for satisfying the at least one payment criterion a well as an additional fixed amount if the customer has a specified relationship (such as a checking and/or a savings account) with the financial institution. | 06-04-2015 |
Colleen Novielli, Evanston, IL US
Patent application number | Description | Published |
---|---|---|
20140207548 | Reward Program for Loan Accounts - A computer system enables a financial institution to award a fixed reward that may include one or more fixed components based on at least one payment criterion when a customer remits a payment in a timely basis. The payment criteria, for example, may include paying a minimum amount for each consecutive billing period in a timely manner over a predetermined calendar interval. When the customer is awarded the fixed reward, the reward may be directed to an account that is designated by the customer. The fixed reward may also include a basic fixed amount for satisfying the at least one payment criterion a well as an additional fixed amount if the customer has a specified relationship (such as a checking and/or a savings account) with the financial institution. | 07-24-2014 |
Colleen Payne-Baggetta, Columbia, SC US
Patent application number | Description | Published |
---|---|---|
20110094114 | Razor handle extension shaving assembly - Razor handle extension shaving assembly for extending the reach of a razor shaving apparatus via handle means. There is disclosed a razor handle extension shaving assembly that is easy to use and manufacture having a simplistic, yet efficient design for a handle extension assembly having a substantially unitary structure without relative moving parts. The assembly is comprised of lightweight materials and containing an array of fluid flow apertures for facilitating use in wet and/or slippery conditions. A unique razor device retention mechanism consisting of a frictional grip means and razor receiving means operatively coupled to one another are distinctive features and said means is adapted to receive a variety of differently sized razor devices. Another feature of the assembly lies in a unique handle structure having an angled portion along a reduced diameter middle portion. | 04-28-2011 |
Colleen Robertson, New Market, MD US
Patent application number | Description | Published |
---|---|---|
20150335777 | PROCESS CHALLENGE DEVICE FOR GAS STERILIZATION - A process challenge device includes a controllable response produced by using a filter material, configured such that a sterilant gas must pass through the filter material to reach the biological indicator (BI). The filter material provides a controllably absorptive barrier, where the absorption of the sterilant is via chemical reaction, through which the sterilant gas must pass to reach the BI. | 11-26-2015 |
Colleen Ruegger, Morris Plains, NJ US
Patent application number | Description | Published |
---|---|---|
20080311188 | SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING A SIP RECEPTOR AGONIST AND A SUGAR ALCOHOL - A solid pharmaceutical composition suitable for oral administration, comprising: | 12-18-2008 |
20090203798 | Solid Pharmaceutical Compositions Comprising a SIP Receptor Agonist and a Sugar Alcohol - A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol. | 08-13-2009 |
20100040678 | ORGANIC COMPOUNDS - The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition having a coating. In other aspects, rapid disintegrating compositions are provided. In a further aspect, a pharmaceutical composition which is free of sugar alcohols is provided. In another aspect, the invention provides a pharmaceutical composition comprising a coating comprising an S1P receptor modulator. | 02-18-2010 |
20100267675 | Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators - The present invention relates to stable compositions comprising a sphingosine 1 phosphate (S1P) receptor modulator, suitable for use as a dosage form. The S1P receptor modulators are typically sphingosine analogues, such as 2-substituted 2-amino-propane-1,3-diol or 2-amino-propanol derivatives, e.g. a compound comprising a group of formula Y. | 10-21-2010 |
20100267786 | DUAL ACTING PHARMACEUTICAL COMPOSITIONS BASED ON SUPERSTRUCTURES OF ANGIOTENSIN RECEPTOR ANTAGONIST/BLOCKER (ARB) AND NE UTRAL ENDOPEPTIDASE (EP) INHIBITOR - Solid oral dosage forms, especially tablets, of a pharmaceutical composition comprising a supramolecular complex can be formed from a direct compression process or a compaction process such as roller compaction. Such solid oral dosage forms feature an immediate release profile that allows for fast release of the therapeutic agent. A particularly useful supramolecular complex is trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3′-methyl-2′-(pentanoyl{2″-(tetrazol-5-ylate)biphenyl-4′-ylmethyl}amino)butyrate]hemipentahydrate. | 10-21-2010 |
20110105620 | ORGANIC COMPOUNDS - A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol. | 05-05-2011 |
20120288559 | ORGANIC COMPOUNDS - The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition having a coating. In other aspects, rapid disintegrating compositions are provided. In a further aspect, a pharmaceutical composition which is free of sugar alcohols is provided. In another aspect, the invention provides a pharmaceutical composition comprising a coating comprising an S1P receptor modulator. | 11-15-2012 |
20130108675 | ORGANIC COMPOUNDS | 05-02-2013 |
20140011885 | Organic Compounds - A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol. | 01-09-2014 |
20140142192 | Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators - The present invention relates to stable compositions comprising a sphingosine 1 phosphate (S1P) receptor modulator, suitable for use as a dosage form. The S1P receptor modulators are typically sphingosine analogues, such as 2-substituted 2-amino-propane-1,3-diol or 2-amino-propanol derivatives, e.g. a compound comprising a group of formula Y. | 05-22-2014 |
20140255497 | Organic Compounds - A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol. | 09-11-2014 |
Colleen Small-Vollmann, Columbia, MO US
Patent application number | Description | Published |
---|---|---|
20080196270 | Heel retainers for open-heeled footwear - Disclosed is a heel retainer for retaining a heel of a wearer on an open-heeled shoe or a closed-back shoe with a low counter. The heel retainer includes a pad having opposed first and second adhesive surfaces. The first adhesive surface is adapted to contact the heel of the wearer and the second adhesive surface is adapted to be detachably adhered to a heel area of a shoe sole. The first adhesive surface retains the heel of the wearer on the heel area of the shoe sole and reduces the possibility slippage during use, thereby providing more comfort and ease to the wearer. In one form, the heel retainer can be easily attached/removed to/from the shoe according to the needs of a wearer without adversely affecting the integrity of the shoe. | 08-21-2008 |
Colleen Taylor, West Sacramento, CA US
Patent application number | Description | Published |
---|---|---|
20150299754 | STREPTOMYCES MICROFLAVUS STRAINS AND METHODS OF THEIR USE TO CONTROL PLANT DISEASES AND PESTS - The present invention relates to novel strains of | 10-22-2015 |
Colleen Trater, Glen Carbon, IL US
Patent application number | Description | Published |
---|---|---|
20090123629 | Tofu Hydrated Structured Protein Compositions - The present invention discloses a structured protein composition which includes a structured protein product which can be combined with tofu, soy whey, or soymilk and a coagulant to form the structured protein composition. Restructured meat compositions and restructured food compositions which include the structured protein composition are also included. | 05-14-2009 |
Colleen Tuell, Long Beach, WA US
Colleen Weins, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20090046281 | Method and System for Automated Inspection System Characterization and Monitoring - A method and system characterizing and monitoring an automated inspection system are provided. A method for automatically characterizing an automatic inspection system for photomasks may include removing portions of an optical attenuator layer disposed on a substrate in order to expose portions of the substrate and create a plurality of test features. The may further include forming a plurality of programmed defects, on the optical attenuator layer, the plurality of programmed defects comprising at least one of an optical reflector and an optical absorber. | 02-19-2009 |